2023-03-30 11:51:13 ET
- Rockwell Medical ( NASDAQ: RMTI ) is trading 8.2% higher after the company posted better-than-expected Q4 results, helped by strong sales of its hemodialysis products.
- The company also forecast net sales for 2023 between $78M to $82M, the mid-point above consensus of $78.43M and gross profit in the range of $7M to $9M for FY2023.
- Revenue grew 26.1% Y/Y to $19.3M and beat by $2.99M, while Q4 GAAP EPS of -$0.20 beats by $0.19.
- As of December 31, the company had cash of $21.5M.
- Press Release
For further details see:
Rockwell Medical rises ~8% on Q4 beat